Response to CAR-T Cell Therapy Similar for Minority Patients
Progression-free and overall survival similar for minority, nonminority patients receiving CAR-T cell therapy for non-Hodgkin lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.